NEUROSURE Trademark

Trademark Overview

On Thursday, May 10, 2018, a trademark application was filed for NEUROSURE with the United States Patent and Trademark Office. The USPTO has given the NEUROSURE trademark a serial number of 87915744. The federal status of this trademark filing is REGISTERED as of Tuesday, December 31, 2019. This trademark is owned by Laboratory Corporation of America Holdings. The NEUROSURE trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical testing for diagnostic, treatment or screening purposes
neurosure

General Information

Serial Number87915744
Word MarkNEUROSURE
Filing DateThursday, May 10, 2018
Status700 - REGISTERED
Status DateTuesday, December 31, 2019
Registration Number5950911
Registration DateTuesday, December 31, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 19, 2019

Trademark Statements

Goods and ServicesMedical testing for diagnostic, treatment or screening purposes

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, May 18, 2018
Primary Code044
First Use Anywhere DateFriday, May 31, 2019
First Use In Commerce DateFriday, May 31, 2019

Trademark Owner History

Party NameLaboratory Corporation of America Holdings
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBurlington, NC 27215
Party NameLaboratory Corporation of America Holdings
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBurlington, NC 27215
Party NameLaboratory Corporation of America Holdings
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBurlington, NC 27215

Trademark Events

Event DateEvent Description
Monday, May 14, 2018NEW APPLICATION ENTERED
Friday, May 18, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 27, 2018ASSIGNED TO EXAMINER
Thursday, June 28, 2018NON-FINAL ACTION WRITTEN
Thursday, June 28, 2018NON-FINAL ACTION E-MAILED
Thursday, June 28, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 28, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 28, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, December 29, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 28, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 11, 2019ASSIGNED TO LIE
Wednesday, February 13, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, February 27, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 19, 2019PUBLISHED FOR OPPOSITION
Tuesday, March 19, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 14, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, November 14, 2019TEAS STATEMENT OF USE RECEIVED
Monday, November 25, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, November 14, 2019USE AMENDMENT FILED
Monday, November 25, 2019STATEMENT OF USE PROCESSING COMPLETE
Thursday, November 28, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, November 29, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, December 31, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, December 31, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, December 10, 2025TEAS SECTION 8 & 15 RECEIVED

Related Keywords

neurosure screening purposes treatment diagnostic testing medical